BrainsWay Ltd.'s revenue has grown 24% a year over three years, and grown 19% a year over five. Revenue growth, 3-year annual rate: +24% (Medical Devices median +11%). Revenue growth, 5-year rate: +19%, growth has picked up over the last three years. Years of annual history on file: 9, FY2017 to FY2025, as filed.

BWAYBrainsWay Ltd.

Healthcare

$11.23+39% 1Y

$11.23

$7.2552 weeks$17.17

Is it growing?

Excellent

Growing: revenue growing +27% year on year, earnings up +260% year on year, and operating margin widening (+25.1 points).

3 good

Revenue trend+27% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +19% a year.

Earnings trend+260% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+25.1 points operating

Trailing-twelve-month operating margin, 8.3% now against -16.9% a year earlier.

All from SEC EDGAR, as of Dec 31, 2025.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is BWAY growing?

BrainsWay Ltd.'s revenue has grown 24% a year over three years, and grown 19% a year over five.

+24%

Revenue growth, 3-year annual rate · Medical Devices median +11% · compounding fast · compounded from fiscal years as filed

Revenue growth, 5-year rate: +19%
Revenue growth, 5-year rate · +24% over three · growth has picked up over the last three years
Years of annual history on file: 9
Years of annual history on file · FY2017 to FY2025, as filed

Details›